JPRN-UMIN000002887
Recruiting
未知
A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy - LIPS study
Fukuoka University Faculty of Medicine0 sites80 target enrollmentDecember 14, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Fukuoka University Faculty of Medicine
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients with type 1 diabetes mellitus 2\.Patients with cardiovascular disease and with the following conditions Patients who have undergone coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the last 3 months, patients with unstable angina, patients with a history of myocardial infarction, patients with a history of a transient ischemic attack (TIA) within the last 6 months, patients that are NYHA functional class III or IV or with heart failure, and patients with a history of cerebral infarction within the last 3 months 3\. serum Cr\>2\.5mg/dL or eGFR\<30mL/min 4\.Patients with severe liver dysfunction 5\.Patients with secondary hypertension caused by factors other than diabetes mellitus 6\.HbA1c \> 9% 7\.Patients with pregnancy or nursing 8\.Other patients deemed ineligible by an investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study)JPRN-C000000370Japanese Society of Kidney and Lipids200
Completed
Not Applicable
An observational study of renal protection by intravenous amino acid therapy in abdominal aortic aneurysm surgeryabdominal aortic aneurysmJPRN-UMIN000038527ational Cerebral and Cardiovascular Center2,000
Completed
Not Applicable
Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period)Chronic renal failure patient with hypertension under going rennin-angiotensin treatment (ARB/ACE-inhibitor) (preservation period)JPRN-UMIN000002478Kure Kyousai Hospital200
Active, not recruiting
Phase 1
A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated with an intravitreal FA implantEUCTR2005-001589-15-GBBausch & Lomb Incorporated60
Recruiting
Not Applicable
A clinical study to evaluate the effect of renal impairment of the pharmacokinetics of oral administration of Factive Tab. 320mgDiseases of the genitourinary systemKCT0006146Chonnam National University Hospital28